Open research awards

We ensure that only the most promising lung research initiatives receive our funding, thanks to our collaborations with some of Australia’s most respected lung scientists who assess each application for Lung Foundation Australia funding on its potential to make ground-breaking progress in lung disease prevention, detection, treatment and management care.

In 2016 our support for research awards will be almost $700,000:

  • 3 students conducting post-doctoral fellowships
  • 8 PhD scholarships
  • 7 top up/travel and or poster awards

2016/2017 Awards

In partnership with Lung Foundation Australia, Boehringer Ingelheim supports a COPD Research Fellowship to improve the diagnosis and management of Chronic Obstructive Pulmonary Disease in Australia. Specifically, the proposed research must be aimed at developing and/or delivering optimal care to people with COPD.

The Fellowship is available as either a one or two year award, with a value of $A80,000 per annum.

Relevant domains of research inquiry range from evaluation of population screening initiatives; interventions to improve diagnostic accuracy within primary care; through to issues of management in the context of a clinician-patient interaction to system level issues to do with the organisation, financing and performance of the health system, including COPD management of indigenous and ethnic minorities within Australia.

Applications close Monday 31st October 2016.

lung-foundation-australia-boehringer-ingelheim-copd-research-fellowship-2017-2018 (552 KB)

If you need inspiration watch our series of videos featuring four previous recipients, their research, clinical and educational journeys, click here.

The Ivan Cash Research Grant-in-Aid’s creation was made possible by a bequest from Mr Ivan Cash, who sadly died from his idiopathic pulmonary fibrosis (IPF) in 2008. It will be awarded annually to fund research specifically in IPF. Lung Foundation Australia invites applications for the Ivan Cash Research Grant-in-Aid valued at $5,000. This IPF Research Award is open to any individual health care professional or scientist, who will be required to collaborate with the Australian IPF Registry management committee to undertake and publish a specific focused analysis of part of the collected dataset of the Australian IPF Registry. The Australian IPF Registry management committee will provide support to the successful applicant to enable the completion of the required research.

lung-foundation-australia-ivan-cash-research-award-2017 (271 KB)

Applications close 31st October, 2016 at 5pm.

Lung Foundation Australia invites applications for the Lizotte Family Research Award valued at $5,000 – to assist research in interstitial pulmonary fibrosis (IPF). This Research Award is open to any individual health care professional or group of health care professionals who are able to demonstrate an interest in IPF, including respiratory physicians, histopathologists, radiologists, researchers, registrars, trainees, nursing and allied health staff.

The funds may be used as a contribution towards IPF related research or pilot projects, or to fund travel or education with respect to increasing knowledge about IPF.

Applications close 31st October, 2016 at 5pm.

lung-foundation-australia-lizotte-family-research-award-2017 (266 KB)

Lung Foundation Australia invites applications for the Ludwig Engel Grant-in-Aid valued at $5,000 – to assist research in respiratory physiology. For the purpose of this Grant-in-Aid, Physiological Research is the use of any methodologies directed towards the elucidation of organ function and its understanding in a precise, quantitative manner.

The funds may be used as a contribution towards equipment, personnel or other running costs incurred in the conduct of research projects. The Grant-in-Aid is not to be used to fund conference travel or conference attendance.

Applications close 31st October, 2016 at 5pm.

lung-foundation-australia-ludwig-engel-research-award-2017 (264 KB)

Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2017  valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have now been awarded on an annual basis since 2001, and have been highly productive.

Award applications close 5pm Monday 7th November, 2016. 

LFA_Cochrane-Scholarship_2017 (114 KB)

A scholarship of up to $2,000 will be offered to students in health sciences (undergraduate or postgraduate) to study Evidence-Based Medicine in lung conditions that are prevalent and important to Aboriginal and Torres Strait Islanders or Maori children. This scholarship is designed to support activities of the Cochrane Collaboration, which provides systematic up-to-date summaries of reliable evidence on risks and benefits of healthcare. This scholarship has been made available through a NHMRC grant to the Centre of Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children.

cochrane_cre_atsic_airways_2017 (99 KB)

The David Serisier Memorial Award for Translational Research in Bronchiectasis or Respiratory Infectious Disease is for the most appropriate poster or oral presentation at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting to be held 25-28 March 2017 in Canberra, ACT.

This award commemorates David Serisier, who was Chair of Lung Foundation Australia and an Associate Professor of Medicine at the Department of Respiratory Medicine of Mater Adult Hospital in Brisbane at the time of his death in 2015. He graduated from the University of Queensland in 1993 and embarked on a career in respiratory medicine, including several years in the early 2000’s as a Clinical Research Fellow at the UK’s University Hospital in Southampton. With his clinical team, he worked to improve the performance of Respiratory Medicine at the Mater so that it ranked in the Health Roundtable as being the most efficient and effective in the country for the treatment of key respiratory diseases.

After many years of research, David, with his Research team published the BLESS Study – the world first randomised blind study of erythromycin in bronchiectasis, establishing a frozen bank of clinical material and resulting in the establishment of a disease bio-bank that continue to be an invaluable source for research into the future. The Study led to changes in clinical practice around the world with the findings becoming the international standard treatment for chest infections in bronchiectasis. He was recognised internationally as a leader who demonstrated how bench-based and clinical research could productively work together. In 2013, he was invited to join the editorial panel of the Lancer Respiratory Medical Journal.

In 2006, David Serisier was appointed as Treasurer of the Thoracic Society of Australia & New Zealand and simultaneously served as a Director and Vice-President of Cystic Fibrosis Australia. In 2011, he was awarded Staff Specialist “Eminent Status” by the University of Queensland.

David Serisier was influential in the establishment of a Bronchiectasis Registry in Europe and was very involved in working to establish the Australian Bronchiectasis Registry at the time of his death.

This prize of $1,000 provides an opportunity to honour his memory, particularly his unswerving dedication to translational research of the highest standard.

David Serisier Memorial Award 2017 (162 KB)

This award commemorates John R Read who was Professor of Medicine at the University of Sydney at the time of his death in 1971. He had a distinguished career, graduating with First Class Honours from the University of Sydney in 1951, winning the University Medal and the A E Mills Memorial Prize for general proficiency over the whole course.

During his junior resident year, Professor Read developed pulmonary tuberculosis, thereafter accepting an appointment as the Registrar in Thoracic Medicine at Royal Prince Alfred Hospital in 1953. He directed his great intellect and energy towards research in respiratory medicine, pioneering a new era in the management of various forms of respiratory failure in the late 1960’s.

Professor Read enjoyed a well deserved international reputation for the high standard of his clinical research. Several of his research fellows from that time have now achieved eminence in respiratory medicine. Through their own achievements, John Read’s disciples perpetuate his profound influence in Australasia and internationally. As one of the architects of the constitution of The Thoracic Society of Australia and New Zealand (TSANZ), Professor Read played a major role in the development of TSANZ.

This prize of $500 provides an opportunity to honour his memory, particularly his unswerving dedication to physiological research of the highest standard.

John Read Prize 2017 (159 KB)

Applications closed – Winner to be announced

(Value: 4 Travel Grants up to $2,500 + GST)

Lung Foundation Australia are excited to announce that there will be four (4) Travel Grants of $2,500 on offer to post-docs and early stage principal investigators in Australia who are involved in the management, treatment and research of lung cancer and mesothelioma.

This award is to support travel to attend the IASLC’s 17th World Conference on Lung Cancer, to be held in Vienna, Austria from 4th – 7th December 2016.

The aim of this award is to facilitate travel to participate in what the Lung Foundation believes to be an excellent opportunity for the development of emerging clinicians and/or researchers within thoracic cancer-related fields.

LFA Travel Grant application - WCLC2016 Final (332 KB)

2016 Award Winners

Deep Manchanda/Lung Foundation Australia Lung Cancer Research FellowshipDr Atiqur Rahman$80,000 per year, over 2 years
Lung Foundation Australia / Boehringer Ingelheim COPD Research Fellowship 2016/2017 Dr Christian Osadnik$80,000Christian 200px
Universities to co-funded PhD Scholarship in Lung Cancer ResearchUniversity of Melbourne

University of Newcastle

Walter and Eliza Hall Institute
$45,000 each over three years
PhD Scholarship Funding Opportunity – The David Wilson PhD Scholarship in Idiopathic Pulmonary FibrosisUniversity of Sydney - Adelle Jee

University of Newcastle - David Waters
$45,000 over three years
Lung Foundation Australia / Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Research Top-Up Grants 2016/2017University of Newcastle - Dr Vanessa McDonald

University of Sydney - Dr Sabine Zimmermann
$40,000 across the two awards
Grant-in-Aid in Lung Cancer ResearchDr Pei Ding
$10,000
Lung Foundation Australia / Ivan Cash Research Grant-in-Aid Award Dr Helen Jo $5,000Helen Jo 200px
Lung Foundation Australia / Lizotte Family Research Award Gang Liu$5,000
Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research A/Prof. Alex Larcombe, A/Prof. Sandra Orgeig and Dr Emma Parkinson-Lawrence$5,000sandra alex 200px
Lung Foundation Australia / Australian Cochrane Airways Group Scholarship Anke Lenferink $2,500anke 200px
Cochrane Airways Australian Satellite Harshani Jayasinghe$2,000harshani 200px
Lung Foundation Australia / A Menarini Australia Pty Ltd COPD Travel Grants to travel to ATS 2016 Dr Annemarie Lee and Dr Kristin Carson travel grants of up to $3000 + GSTKristin 200px
Lung Foundation Australia / A Menarini Australia Pty Ltd Travel Grants to travel to ERS2016Dr Christian Osadnik and Dr Natasha Smallwoodtravel grants of up to $3000 + GST
Lung Foundation Australia / A Menarini Australia Pty Ltd Travel Grants to travel to APSR 2016Alicia Mitchell and Leanne Rosstravel grants of up to $3000 + GST
David Serisier Memorial Award for Translational Research in Bronchiectasis Dr Greg Fox$1,000